Rescher Leon, Singh Swati, Zahn Ingrid, Paulsen Friedrich, Schicht Martin
Institute of Functional and Clinical Anatomy, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Centre for Ocular Regeneration, L.V. Prasad Eye Institute, Hyderabad 500034, India.
Life (Basel). 2024 Dec 18;14(12):1682. doi: 10.3390/life14121682.
Metformin, a commonly prescribed medication for managing diabetes, has garnered increasing interest as a potential therapeutic option for combating cancer and aging.
The current study investigated the effects of metformin treatment on human meibomian gland epithelial cells (hMGECs) at morphological, molecular, and electron microscopy levels. HMGECs were stimulated in vitro with 1 mM, 5 mM, and 10 mM metformin for 24, 48, and 72 h. The assessed outcomes were cell proliferation assays, lipid production, ultrastructural changes, levels of IGF-1, Nrf2, HO-1, apoptosis-inducing factor 1 (AIF1) at the protein level, and the expression of oxidative stress factors (matrix metallopeptidase 9, activating transcription factor 3, CYBB, or NADPH oxidase 2, xanthine dehydrogenase).
Morphological studies showed increased lipid production, the differentiation of hMGECs after stimulation with metformin, and the differentiation effects of undifferentiated hMGECs. Proliferation tests showed a reduction in cell proliferation with increasing concentrations over time. AIF1 apoptosis levels were not significantly regulated, but morphologically, the dying cells at a higher concentration of 5-10 mM showed a rupture and permeabilization of the plasma membrane, a swelling of the cytoplasm, and vacuolization after more than 48 h. The IGF-1 ELISA showed an irregular expression, which mostly decreased over time. Only at 72 h and 10 mM did we have a significant increase. Mitochondrial metabolic markers such as Nrf2 significantly increased over time, while HO-1 decreased partially. The RT-PCR showed a significant increase in MMP9, CYBB, XDH, and ATF with increasing time and metformin concentrations, indicating cell stress.
Our results using a cell line suggest that metformin affects the cellular physiology of meibomian gland epithelial cells and induces cell stress in a dose- and duration-dependent manner, causing changes in their morphology and ultrastructure.
二甲双胍是一种常用于治疗糖尿病的药物,作为对抗癌症和衰老的潜在治疗选择,其受到的关注日益增加。
本研究在形态学、分子水平和电子显微镜水平上研究了二甲双胍处理对人睑板腺上皮细胞(hMGECs)的影响。用1 mM、5 mM和10 mM二甲双胍在体外刺激hMGECs 24、48和72小时。评估的结果包括细胞增殖测定、脂质生成、超微结构变化、蛋白质水平的胰岛素样生长因子-1(IGF-1)、核因子E2相关因子2(Nrf2)、血红素加氧酶-1(HO-1)、凋亡诱导因子1(AIF1)水平,以及氧化应激因子(基质金属肽酶9、激活转录因子3、细胞色素b-245β链(CYBB)或烟酰胺腺嘌呤二核苷酸磷酸氧化酶2、黄嘌呤脱氢酶)的表达。
形态学研究显示脂质生成增加,二甲双胍刺激后hMGECs分化,以及未分化hMGECs的分化效应。增殖试验显示随着时间推移,细胞增殖随浓度增加而降低。AIF1凋亡水平未受到显著调节,但在形态学上,5-10 mM较高浓度下的死亡细胞在48小时后显示出质膜破裂和通透性增加、细胞质肿胀和空泡化。IGF-1酶联免疫吸附测定显示表达不规则,大多随时间降低。仅在72小时和10 mM时出现显著增加。线粒体代谢标志物如Nrf2随时间显著增加,而HO-1部分降低。逆转录聚合酶链反应显示随着时间和二甲双胍浓度增加,基质金属肽酶9、CYBB、黄嘌呤脱氢酶和激活转录因子显著增加,表明细胞应激。
我们使用细胞系的结果表明,二甲双胍影响睑板腺上皮细胞的细胞生理学,并以剂量和持续时间依赖性方式诱导细胞应激,导致其形态和超微结构发生变化。